Overview
Apokyn is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2004 to treat intermittent “off” episodes in people with advanced Parkinson’s disease. Apokyn is also referred to by its…

Overview
Azilect is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2006 to treat motor symptoms in people with Parkinson’s disease. Azilect may be prescribed as a monotherapy to people…

Overview
Comtan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjunct (add-on) drug to levodopa/carbidopa if the latter drugs begin to lose effectiveness in treating motor symptoms…

Overview
Crexont is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, post-encephalitic parkinsonism (Parkinson-like symptoms following brain inflammation), and parkinsonism…

Overview
Dhivy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, as well as post-encephalitic parkinsonism and symptomatic parkinsonism caused by carbon monoxide or…

Overview
Duopa is a prescription drug approved by the Food and Drug Administration (FDA) in 2015 to treat fluctuating motor symptoms in those with advanced Parkinson’s Disease. Duopa may be prescribed if your condition…

Overview
Eldepryl is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1989 to treat motor symptoms in people with Parkinson’s disease. Eldepryl may be prescribed as a monotherapy to people…

Overview
Exelon is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2000 to treat mild to moderate dementia in people with Parkinson’s disease. Exelon may also be prescribed to treat…

Overview
Gocovri is a prescription drug approved by the U.S.Food and Drug Administration (FDA) to treat dyskinesia (movement disorder) in people with Parkinson’s disease who are also receiving levodopa-based therapy…

Overview
Inbrija is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat “off” episodes in people with Parkinson’s disease (PD) who are taking oral levodopa/carbidopa
Inbrija is an…

Overview
Neupro is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2007 to treat motor symptoms of Parkinson’s disease. Neupro is also referred to by its drug name, rotigotine
Neupro is…

Overview
Northera is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2014 to treat orthostatic hypotension (dizziness upon standing up) in people with Parkinson’s disease. Northera is also…

Overview
Nourianz is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with Parkinson’s experiencing “off” episodes. Nourianz is also referred to by its drug name, istradefylline…

Overview
Nuplazid is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of hallucinations and delusions associated with Parkinson’s disease. Nuplazid is also known by its drug…

Overview
Onapgo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. It is prescribed to individuals who experience “off”…

Overview
Ongentys is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people with Parkinson’s experiencing “off” episodes. Ongentys is also referred to by its drug name, opicapone…

Overview
Parlodel is a prescription drug approved by the Food and Drug Administration (FDA) to treat the symptoms of Parkinson’s. Parlodel is also indicated to treat acromegaly, as well as problems associated with…

Overview
Rytary is a prescription drug approved by the Food and Drug Administration (FDA) in 2015 to treat motor symptoms of Parkinsonism caused by Parkinson’s Disease, encephalitis, or exposure to carbon monoxide or…

Overview
Sinemet is a prescription drug approved by the Food and Drug Administration (FDA) in 1975 to treat motor symptoms of Parkinsonism caused by Parkinson’s Disease, encephalitis, or exposure to carbon monoxide or…

Overview
Stalevo is a prescription drug approved by the Food and Drug Administration (FDA) in 2003 to treat motor symptoms of Parkinson’s Disease. Stalevo is often prescribed in cases of advanced Parkinson’s Disease when…

Overview
Tasmar is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1998. Tasmar is prescribed as an adjunct (add-on) drug to levodopa/carbidopa if the latter drugs begin to lose…

Overview
Trihexyphenidyl is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in all forms of parkinsonism. Trihexyphenidyl is often prescribed to younger people with…

Overview
Vyalev is approved by the U.S. Food and Drug Administration (FDA) for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. This treatment is intended for individuals who experience…

Overview
Xadago is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an add-on medication to treat Parkinson’s disease. Xadago is indicated for people who are taking levodopa/carbidopa but…

Overview
Zelapar is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in people with Parkinson’s disease. Zelapar may be prescribed as a monotherapy to people with early…